UPDATE : Wednesday, January 22, 2020
상단여백
HanAll remains positive of eye treatment’s efficacy despite initial failure
HanAll Biopharma said that it has failed to meet the primary endpoint for i...
by Lee Han-soo  |  2020-01-21 15:12
라인
SK Biopharma’s US partner gets EMA nod for sleepiness treatment
Jazz Pharmaceuticals, SK Biopharmaceutical’s U.S. partner, has received sal...
by Lee Han-soo  |  2020-01-21 14:22
라인
Some Merck Korea workers commute from provinces to Seoul every day
Merck Biopharma Korea completed the closure of the general medicine (GM) di...
by Kim Yun-mi  |  2020-01-21 14:21
라인
Daewoong’s Jeuveau sold ₩40 billion in US in 8 months
Daewoong Pharmaceutical said the U.S. sales of its botulinum toxin Nabota (...
by Jeong Sae-im  |  2020-01-21 11:43
라인
CoImmune acquires Formula Pharmaceuticals
CoImmune, a joint venture set up by SCM Life Science and Genexine in the U....
by Lee Han-soo  |  2020-01-20 15:45
라인
Pfizer’s spinoff of generics unit causes disputes with trade union
Pfizer’s spinoff of its generics business division has made the employment ...
by Kim Yun-mi  |  2020-01-20 15:44
라인
Korea’s botulinum toxin exports hit record high in 2019
Exports of botulinum toxin products recorded the largest volume last year i...
by Jeong Sae-im  |  2020-01-20 11:38
라인
Takeda’s Kynteles expands indication for ulcerative colitis, Crohn’s disease
People with ulcerative colitis and Crohn’s disease who have failed with sta...
by Kim Yun-mi  |  2020-01-17 17:30
라인
GenScript to market Genopis' GMP-grade plasmid DNA
Genopis, a U.S offshoot of Helixmith, said that it has entered into a strat...
by Lee Han-soo  |  2020-01-17 17:28
라인
AbbVie says its psoriasis drug superior to Novartis’ treatment
AbbVie said its psoriasis treatment Skyrizi met both primary and all-ranked...
by Lee Han-soo  |  2020-01-17 17:28
라인
HanAll, Daewoong unveil P3 topline results for dry eye treatment
HanAll Biopharma and Daewoong Pharmaceutical said that they have presented ...
by Lee Han-soo  |  2020-01-16 15:46
라인
Genome to conduct immunotherapy combo trial with Merck, Pfizer
Genome & Company, a local clinical-stage biotechnology business, said that ...
by Lee Han-soo  |  2020-01-16 14:47
라인
GSK to target ovarian cancer, multiple myeloma, endometrial cancer
After entering the oncology market with the acquisition of Tesaro in late 2...
by Kim Yun-mi  |  2020-01-16 14:10
라인
Sweden prolongs financial support for IVI’s vaccine development
The International Vaccine Institute (IVI) said that the Swedish Internation...
by Lee Han-soo  |  2020-01-16 10:45
라인
Pharmaceutical association lays out plans for 2020
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) l...
by Lee Han-soo  |  2020-01-15 14:29
라인
AptaBio attending J.P. Morgan event for global collaboration
AptaBio, a maker of drugs to treat cancer and diabetic complications, said ...
by Shim Hyun-tai  |  2020-01-15 13:06
라인
GC Pharma's US offshoot opens new plasma center
GC Pharma said Green Cross America (GCAM), its U.S. branch to secure plasma...
by Shim Hyun-tai  |  2020-01-15 13:05
라인
Jeil, Oncocross to discover new indications for stroke therapy
Jeil Pharmaceutical said that it will partner with Oncocross, a local ventu...
by Lee Han-soo  |  2020-01-15 11:31
라인
Will Steglatro prove SGLT-2 inhibitor’s cardiovascular benefits?
MSD is expected to announce the results of a study, whether Steglatro (ingr...
by Kim Yun-mi  |  2020-01-14 15:28
라인
Genexine becomes largest shareholder of GenNBio
GenNBio said that Genexine has become its largest shareholder. The announce...
by Lee Han-soo  |  2020-01-14 11:11
여백
여백
여백
Back to Top